CLSD

Clearside Biomedical, Inc. · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website clearsidebio.com
Employees(FY) 36
ISIN US1850631045

Performance

-5.41%

-8.7%

+2.94%

-19.85%

-10.26%

YTD

+8.06%

Profile

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase 1/2a clinical trial; and CLS-301, an integrin inhibitor suspension for the treatment of diabetic macular edema and macular degeneration. Clearside Biomedical, Inc. has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., and Aura Biosciences. The company was incorporated in 2011 and is headquartered in Alpharetta, Georgia.

Advanced Technical Analysis

Technical Analysis of CLSD 2024-11-20

The stock's Moving Average Score of 10 indicates a strong bearish sentiment, while the Oscillators Score of 56 suggests a neutral stance. Overall, the Technical Score of 33 reinforces the bearish outlook, indicating that the stock may face downward pressure in the near term.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of CLSD

Stock Rank

Recent News & Updates

2024-11-14 23:00
All You Need to Know About Clearside Biomedical (CLSD) Rating Upgrade to Buy(Yahoo Finance)
2024-11-12 13:17
Clearside Biomedical Inc (CLSD) Q3 2024 Earnings Call Highlights: Promising Clinical Trial ...(Yahoo Finance)
2024-11-12 05:05
Clearside Biomedical, Inc. (CLSD) Reports Q3 Loss, Tops Revenue Estimates(Yahoo Finance)
2024-11-12 03:05
Clearside Biomedical Announces Third Quarter 2024 Financial Results and Provides Corporate Update(Globenewswire)
2024-11-10 18:23
Clearside Biomedical Inc (CLSD) Q3 2024 Earnings Report Preview: What to Look For(Yahoo Finance)
2024-11-07 14:56
Santen, Arctic Vision sign deal for ARVN001 to treat UME(Yahoo Finance)
2024-11-06 20:05
Clearside Biomedical Partner Arctic Vision Executes Commercial Collaboration Agreement with Santen Pharmaceutical Co., Ltd for ARVN001 Suprachoroidal Space Injection Therapy for the Treatment of Uveitic Macular Edema(Globenewswire)
2024-11-05 18:05
Clearside Biomedical to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference(Globenewswire)
2024-11-03 18:05
Clearside Biomedical Appoints Tony Gibney as New Chair of the Board of Directors(Globenewswire)
2024-10-30 19:05
Clearside Biomedical to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Tuesday, November 12, 2024(Globenewswire)
2024-10-21 19:05
Clearside Biomedical's Positive ODYSSEY Wet AMD Data and Suprachoroidal Injection Platform Highlighted in Presentations at Multiple Events During AAO 2024 Annual Meeting(Globenewswire)
2024-10-09 20:57
Morning Movers: Arcadium Lithium surges after deal to be acquired(Yahoo Finance)
2024-10-08 22:22
Clearside Biomedical's Investigational Drug For Vision Loss Hits Primary Goals In Mid-Stage Study(Yahoo Finance)
2024-10-08 18:30
Clearside Biomedical Announces Positive Topline Results from ODYSSEY Phase 2b Trial of Suprachoroidal CLS-AX in Wet AMD Achieving All Primary and Secondary Outcomes(Globenewswire)
2024-08-26 19:05
Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD(Globenewswire)
2024-08-14 21:35
After Plunging -15.7% in 4 Weeks, Here's Why the Trend Might Reverse for Clearside Biomedical (CLSD)(Yahoo Finance)
2024-08-12 05:25
Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Lags Revenue Estimates(Yahoo Finance)
2024-08-12 04:05
Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate Update(Globenewswire)
2024-08-07 19:05
Clearside Biomedical to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference(Globenewswire)
2024-08-04 22:00
Clearside Biomedical, Inc. (CLSD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?(Yahoo Finance)
2024-07-31 19:05
Clearside Biomedical to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024(Globenewswire)
2024-07-29 04:05
Clearside Biomedical's Partner Arctic Vision Reports Positive Topline Results from Phase 3 Clinical Trial of ARCATUS for Suprachoroidal Use in Uveitic Macular Edema Patients in China(Globenewswire)
2024-07-22 00:00
Clearside Biomedical Opens Registration for Suprachoroidal Delivery KOL Webinar to Be Held on Wednesday, July 24, 2024 at 8:00 am ET(Globenewswire)
2024-07-10 19:05
Clearside Biomedical Appoints Dr. Glenn Yiu to its Scientific Advisory Board(Globenewswire)
2024-06-26 19:05
Clearside Biomedical to Host Virtual Key Opinion Leader Event on the Use and Versatility of Suprachoroidal Drug Delivery(Globenewswire)
2024-06-11 19:05
Clearside Biomedical's Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit Meeting(Globenewswire)
2024-05-20 19:05
Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS ) Injection in Leading Peer-Reviewed Industry Journal, RETINA(Globenewswire)
2024-05-12 20:20
HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating(Yahoo Finance)
2024-05-10 02:15
Q1 2024 Clearside Biomedical Inc Earnings Call(Yahoo Finance)
2024-05-09 23:56
Clearside Biomedical, Inc. (NASDAQ:CLSD) Q1 2024 Earnings Call Transcript(Yahoo Finance)

Page 1 of 5

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.